Cargando…
Acellular Pertussis Vaccine Components: Today and Tomorrow
Pertussis is a highly communicable acute respiratory infection caused by Bordetella pertussis. Immunity is not lifelong after natural infection or vaccination. Pertussis outbreaks occur cyclically worldwide and effective vaccination strategies are needed to control disease. Whole-cell pertussis (wP)...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349526/ https://www.ncbi.nlm.nih.gov/pubmed/32414005 http://dx.doi.org/10.3390/vaccines8020217 |
_version_ | 1783557075151880192 |
---|---|
author | Dewan, Kalyan K. Linz, Bodo DeRocco, Susan E. Harvill, Eric T. |
author_facet | Dewan, Kalyan K. Linz, Bodo DeRocco, Susan E. Harvill, Eric T. |
author_sort | Dewan, Kalyan K. |
collection | PubMed |
description | Pertussis is a highly communicable acute respiratory infection caused by Bordetella pertussis. Immunity is not lifelong after natural infection or vaccination. Pertussis outbreaks occur cyclically worldwide and effective vaccination strategies are needed to control disease. Whole-cell pertussis (wP) vaccines became available in the 1940s but have been replaced in many countries with acellular pertussis (aP) vaccines. This review summarizes disease epidemiology before and after the introduction of wP and aP vaccines, discusses the rationale and clinical implications for antigen inclusion in aP vaccines, and provides an overview of novel vaccine strategies aimed at better combating pertussis in the future. |
format | Online Article Text |
id | pubmed-7349526 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73495262020-07-14 Acellular Pertussis Vaccine Components: Today and Tomorrow Dewan, Kalyan K. Linz, Bodo DeRocco, Susan E. Harvill, Eric T. Vaccines (Basel) Review Pertussis is a highly communicable acute respiratory infection caused by Bordetella pertussis. Immunity is not lifelong after natural infection or vaccination. Pertussis outbreaks occur cyclically worldwide and effective vaccination strategies are needed to control disease. Whole-cell pertussis (wP) vaccines became available in the 1940s but have been replaced in many countries with acellular pertussis (aP) vaccines. This review summarizes disease epidemiology before and after the introduction of wP and aP vaccines, discusses the rationale and clinical implications for antigen inclusion in aP vaccines, and provides an overview of novel vaccine strategies aimed at better combating pertussis in the future. MDPI 2020-05-13 /pmc/articles/PMC7349526/ /pubmed/32414005 http://dx.doi.org/10.3390/vaccines8020217 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Dewan, Kalyan K. Linz, Bodo DeRocco, Susan E. Harvill, Eric T. Acellular Pertussis Vaccine Components: Today and Tomorrow |
title | Acellular Pertussis Vaccine Components: Today and Tomorrow |
title_full | Acellular Pertussis Vaccine Components: Today and Tomorrow |
title_fullStr | Acellular Pertussis Vaccine Components: Today and Tomorrow |
title_full_unstemmed | Acellular Pertussis Vaccine Components: Today and Tomorrow |
title_short | Acellular Pertussis Vaccine Components: Today and Tomorrow |
title_sort | acellular pertussis vaccine components: today and tomorrow |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349526/ https://www.ncbi.nlm.nih.gov/pubmed/32414005 http://dx.doi.org/10.3390/vaccines8020217 |
work_keys_str_mv | AT dewankalyank acellularpertussisvaccinecomponentstodayandtomorrow AT linzbodo acellularpertussisvaccinecomponentstodayandtomorrow AT deroccosusane acellularpertussisvaccinecomponentstodayandtomorrow AT harvillerict acellularpertussisvaccinecomponentstodayandtomorrow |